摘要
目的 ：探讨超声内镜（endoscopic ultrasonography,EUS）引导下瘤体内注射H101治疗胰腺癌的方法及疗效。方法：92例中晚期胰腺癌根据意愿分为H101组（n=40）及化疗组（n=52）。其中H101组给予EUS引导下瘤体内注射H101联合吉西他滨治疗,化疗组给予静脉注射吉西他滨单药化疗。分析治疗后瘤体变化、KPS及VAS评分、生存分析及治疗不良反应。结果：H101组治疗4、12个月后部分缓解（PR）率及有效率（40.0%,62.5%）均显著高于化疗组（16.7%,20.0%）（P〈0.05）。H101组及化疗组12个月内存活患者KPS评分在治疗4、8、12个月后均较治疗前显著升高（P〈0.05）,VAS评分均显著降低（P〈0.05）,而2组之间相比各时间点VAS及KPS评分均无显著差异（P〉0.05）。H101组12个月内病死率（60.0%）较化疗组（80.8%）显著降低（χ2=4.810,P=0.028）。H101组中位生存期为（8.8±0.5）个月（95%CI：7.87～9.68）,较化疗组（7.6±0.4）个月显著延长（χ2=3.976,P=0.046）。结论：EUS引导下瘤体内注射H101联合吉西他滨治疗中晚期胰腺癌是安全有效的,有助于提高患者生存质量、延长生存期。
Objective：To explore the methods and effects of tumor injection of H101 guided by endoscopic ultrasonography（EUS）for patients with pancreatic carcinoma. Methods：A total of 92 patients with advanced pancreatic carcinoma were divided into the H101 group（n=40） and the chemotherapy group（n=52）. The patients in the H101 group were treated by tumor injection of H101 guided by EUS complicated with gemcitabine and the patients in the chemotherapy group were treated only by gemcitabine. The changes of tumor body,VAS and KPS score,survival analysis,and adverse reaction were analyzed. Results：The partial remission（PR）rate and effective rate of the H101 group（40.0%,62.5%） was higher than those of the chemotherapy group（16.7%,20.0%） after4,12 months of treatment（P〈0.05）. The KPS score was elevated after 4,8 and 12 months of treatment and VAS score was decreased（P〈0.05）,but there was no difference in the two groups（P〈0.05）. The mortality of the H101 group（60.0%） in 12 months was decreased than that of the chemotherapy group（80.8%）（χ2=4.810,P=0.028）. The mid-life span of the H101 group was（8.8 ±0.5） months and prolonged than that of the chemotherapy group [（7.6 ± 0.4）months,χ2=3.976,P=0.046]. Conclusion：Tumor injection of H101 guided by EUS is safe and feasible for patients with advanced pancreatic carcinoma,and is helpful to improve the life quality and prolong life span.
出处
《南京医科大学学报（自然科学版）》
CAS
CSCD
北大核心
2016年第10期1166-1169,1187,共5页
Journal of Nanjing Medical University(Natural Sciences)
基金
无锡市科技局指令性项目(CSE01N1217)
关键词
超声内镜
瘤体内注射
H101
胰腺癌
疗效
endoscopic ultrasonography
tumor injection
H101
pancreatic carcinoma
therapeutic effects
